Patients With Relapsed Ovarian Cancer (2nd and 3rd Line) Treated With Chemotherapy According to AGO Guidelines

NCT03622931 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

21

Enrollment

OTHER

Sponsor class

Stopped due to lack of recruitment

Conditions

Ovarian Cancer

Interventions

DRUG: Standard chemotherapy
DRUG: Romiplostim
DRUG: Placebos

Sponsor

Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH